Jupiter Asset Management’s Sage Therapeutics SAGE Stock Holding History

Jupiter Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-49,793	Closed	-$1.02M	–	528
2023 Q3	$1.02M	Buy	+49,793	New	+$1.44M	0.01%	399
2023 Q1	–	Sell	-40,137	Closed	-$1.53M	–	491
2022 Q4	$1.53M	Buy	+40,137	New	+$1.53M	0.02%	339
2022 Q1	–	Sell	-30,671	Closed	-$1.33M	–	603
2021 Q4	$1.33M	Hold	30,671	–	–	0.01%	400
2021 Q3	$1.36M	Sell	30,671 -13,600	-31%	-$624K	0.02%	383
2021 Q2	$2.51M	Buy	44,271 +36,229	+450%	+$2.56M	0.03%	374
2021 Q1	$602K	Hold	8,042	–	–	0.01%	470
2020 Q4	$696K	Buy	+8,042	New	+$593K	0.01%	486

Other funds holding SAGE

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Asset Management's SAGE Position: Q4 2023 in Review

Jupiter Asset Management sold out of Sage Therapeutics (SAGE) in Q4 2023, closing a stake of 49,793 shares — an estimated $1.02M sold.

Jupiter Asset Management first reported a position in SAGE in Q4 2020 and held it in 7 quarters. The position peaked at $2.51M in Q2 2021. 201 funds tracked by Wall St. Rank hold SAGE as of Q4 2023.

Jupiter Asset Management reported no remaining Sage Therapeutics position as of Q4 2023 after selling out during the quarter.
Jupiter Asset Management sold 49,793 Sage Therapeutics shares in Q4 2023, an estimated $1.02M.
Jupiter Asset Management first reported a position in Sage Therapeutics in Q4 2020 and held it in 7 quarters.
Jupiter Asset Management's Sage Therapeutics position peaked at $2.51M in Q2 2021.
201 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2023.

Based on Jupiter Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.